The Quantellect read.As of Nov 19, 2026, 4 active firms cover Alvotech: 4 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $6.00 to $8.00, so the covering firms are broadly aligned. The average target of $7.00 sits 54% above the current $4.55. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees revenue growth near 12% this year and 19% next.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Buy
Strong Buy00%
Buy4100%
Neutral00%
Sell00%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$7.00
+53.8% upside
Average target across 3 active firms as of Nov 19, 2026 vs $4.55 current
Highest Target$8.00
Average Target$7.00
Lowest Target$6.00
Detailed analyst forecasts for ALVO
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 4 of 4 active firms rate ALVO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ALVO EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 1 analysts
Next period, 1 analysts expect Alvotech to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $-0.02, growing to $0.21 the year after.
REVENUE · NEXT QUARTER
$171.2M
Range $171.2M – $171.2M · 1 analysts · +52% YoY
Revenue is expected to reach $171.2M (range $171.2M – $171.2M), +52.0% year-over-year. Full-year consensus is $651.3M, rising to $797.7M next year.
Top analysts covering Alvotech
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ALVO.
#1
Jason Gerberry
B of A Securities · Rank #160
Buy
$7.00+53.8% to target
Overall win rate
47%
+ Follow
#2
GS
Glen Santangelo
Barclays
Buy
$8.00+75.8% to target
Coverage
—
+ Follow
#3
NA
Niall Alexander
Deutsche Bank
Neutral
$4.00-12.1% to target
Coverage
—
+ Follow
#4
Ashwani Verma
UBS
Buy
$6.00+31.9% to target
Coverage
—
+ Follow
#5
TB
Thibault Boutherin
Morgan Stanley
Buy
$10.00+119.8% to target
Coverage
—
+ Follow
ALVO stock forecast FAQ
What is ALVO's average 12-month price target?+
The 3 active firms with a live target average $7.00 for Alvotech over the next 12 months, ranging from a $8.00 high to a $6.00 low, as of Nov 19, 2026.
Is ALVO stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 4 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ALVO?+
The Street-high target is $8.00 (Barclays), and the Street-low is $6.00 (UBS). The average of all 3 active-firm targets is $7.00.
How many active Wall Street firms cover ALVO?+
4 active firms have a recognized rating on Alvotech as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ALVO?+
Among analysts who currently cover ALVO, Jason Gerberry of B of A Securities has the strongest overall Quantellect track record (Rank #160). Their current call is Buy with a $7.00 target.
What is Alvotech's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 1 analysts. Full-year EPS is projected at $-0.02, rising to $0.21 the following year.
How much revenue is Alvotech expected to report next quarter?+
Consensus revenue is $171.2M (range $171.2M – $171.2M). Full-year revenue is projected at $651.3M, growing to $797.7M next year.
Have analysts been upgrading or downgrading ALVO lately?+
As of Nov 19, 2026, 4 of 4 active firms rate ALVO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ALVO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.